Characteristics of children hospitalized with infective endocarditis

Michael D Day1, Kimberlee Gauvreau, Stanford Shulman

  • 1Department of Cardiology, Children's Hospital Boston and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.

Circulation
|February 4, 2009
PubMed

Insights

Pediatric infective endocarditis (IE) is shifting towards children without heart conditions. Risk factors for death in children with IE include congenital heart disease, premature birth, and Staphylococcus aureus infections.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Infective endocarditis (IE) in children is a rare condition.
  • Most existing data on pediatric IE comes from specialized referral centers.
  • This study aims to describe IE characteristics in a broad national pediatric sample.

Purpose of the Study:

  • To assess the epidemiological characteristics of infective endocarditis in children.
  • To identify trends and risk factors associated with pediatric IE.
  • To analyze outcomes and mortality in pediatric IE cases.

Main Methods:

  • Analysis of hospital discharge records from the Kids' Inpatient Databases (2000 and 2003).
  • Inclusion criteria: patients under 21 years of age with IE diagnosis codes.
  • Combined analysis of data from both years.

Main Results:

  • A total of 1588 hospitalizations for pediatric IE were analyzed.
  • The age distribution showed peaks in infancy and late adolescence.
  • Staphylococcus aureus was the most common pathogen (57%), followed by viridans streptococci (20%).
  • Preexisting heart disease was present in 42% of patients, predominantly congenital heart disease (81%).
  • In-hospital mortality was 5% (84 patients), with higher rates in specific congenital heart defects and prosthetic valve endocarditis.
  • Among deaths without preexisting heart disease, S. aureus was prevalent in older children, while prematurity was a factor in infants.

Conclusions:

  • Pediatric IE epidemiology shows a trend towards increased cases without preexisting heart disease.
  • Congenital heart disease and prosthetic valve endocarditis are significant risk factors for mortality.
  • In non-congenital heart disease cases, premature/neonatal age and S. aureus infection are key mortality predictors.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...